Evaluation of Graft Material in Coronary Artery Bypass Grafting (CABG)
NCT ID: NCT01310725
Last Updated: 2011-03-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
108 participants
INTERVENTIONAL
2004-01-31
2010-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The hypothesis is that vein grafts harvested with a pedicle of surrounding tissue have the same, or better, patency compared to radial grafts and that skeletonisation of the left internal mammary artery does not effect the patency for this graft.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Vein vs Arterial Grafts for Coronary Artery Bypass Grafting Surgery
NCT02158455
Five-year Patency of No-touch Saphenous Vein Grafts in On-pump Versus Clamp-less Off-pump Coronary Artery Bypass Surgery
NCT03447197
The Long-term Results of the No-touch Vein Graft to the Left Anterior Descending Artery.
NCT02339857
Radial Artery Patency and Clinical Outcomes Trial
NCT00475488
Radial Artery Versus No-touch Saphenous Vein
NCT06014047
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Each patient receive a radial artery graft and a vein graft harvested with a pedicle of surrounding tissue to the right and left side of the heart respectively. The left internal mammary artery is used for the left anterior descending artery in a skeletonised or non-skeletonised fashion.
The evaluation is made with angiography up to 5 years after surgery.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
TREATMENT
SINGLE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Coronary artery bypass grafting
Bypass of stenoses in coronary arteries using different types os vessels as conduit.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* War-farin anticoagulation therapy
* Ejection fraction \< 40%
* Repeat operation
* Other concurrent sur-gery
* Signs of reduced circulation in non-dominant hand
* Other severe illness, or if the patient declines to participate.
30 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Swedish Heart Lung Foundation
OTHER
Regional Clinical Research
OTHER
Region Örebro County
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
University Hospital Orebro
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lars Norgren, MD, PhD, Prof.
Role: STUDY_CHAIR
OREBRO UNIVERSITY
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Dept of Cardiothoracic Surgery, Orebro University Hospital
Örebro, , Sweden
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
mdr001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.